Status:
RECRUITING
Web-based Intervention for Long-term Breast Cancer Survivors
Lead Sponsor:
Cristina García-Vivar
Collaborating Sponsors:
Instituto de Salud Carlos III
Conditions:
Long-term Effects of Cancer Treatment
Long-term Effects Secondary to Cancer Therapy in Adults
Eligibility:
FEMALE
18-99 years
Phase:
NA
Brief Summary
The number of breast cancer survivors is growing. More cured women are becoming long-term survivors of breast cancer (LS-BC) at least 5 years after diagnosis and after treatment has been completed. So...
Detailed Description
Hypothesis: A web-based tailored intervention, based on the prevention and management of physical and psychosocial late effects due to cancer treatment and aimed at improving the coexistence of long-t...
Eligibility Criteria
Inclusion
- having been diagnosed with breast cancer
- having completed active oncological treatments (chemotherapy and/or radiotherapy) in a period of time greater than five years,
- be free of disease at the time of data collection
- be a woman and over 18 years of age
- have knowledge of Internet use.
Exclusion
- Women with a diagnosis of cancer other than breast cancer
- Recurrence of cancer or metastasis that causes a new treatment
- Being in active treatment for recurrence or new cancer
- Being a man
Key Trial Info
Start Date :
December 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT05322460
Start Date
December 15 2023
End Date
November 1 2025
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Public University of Navarre
Pamplona, Spain, 31008